5.0 60 6 9* 63 6 7* 65 6 14*
Nilai rata-rata adalah 6 SD, n = 3. Infektivitas dengan tidak adanya oligosakarida dianggap
100% (G1P [8]: 100% 6 8%, G2P [4]: 100% 6 16%). Data diekspresikan relatif terhadap kontrol
no-oligosaccharide. * Berbeda dari kontrol, P, 0,01; # berbeda dari 3 # SL + 6 # SL, P, 0,01.
MA104, sel epitel ginjal monyet hijau Afrika; 3 # SL, 3 # -sialyllactose; 6 # SL, 6 # -sialyllactose.
GAMBAR 2 Susu oligosakarida mengurangi infektivitas strain
rotavirus manusia dalam sel MA104. Efek oligosakarida susu (2 #
FL, GOS, 3 # SL, dan 6 # SL) pada infektivitas 2 strain rotavirus
manusia yang relevan secara klinis G1P [8] (A) dan G2P [4] (B) diuji
(lihat Gambar 1, kondisi 1 untuk pengaturan eksperimental). Data
berarti 6 SD, dan $ 3 percobaan independen. Infektivitas dengan tidak
adanya oligosakarida dianggap 100% (G1P [8]: 100% 6 8%, G2P [4]:
100% 6 16%) (garis putus-putus hitam). Data diekspresikan relatif
terhadap kontrol no-oligosaccharide. * Berbeda dari kontrol, P, 0,01.
GOS, galacto-oligosaccharide; MA104, sel epitel ginjal monyet hijau
Afrika; 2 # FL, 2 # -fucosyllactose; 3 # SL, 3 # -sialyllactose; 6 # SL,
6 # -sialyllactose. mengurangi infektivitas G1P [8] dari 3 # SL dan 6 #
SL bila digunakan secara terpisah, kombinasi dari glycans ini lebih
kuat dalam mengurangi infektivitas G2P [4] daripada reduksi yang
diamati dengan glycans sialylated individu (Tabel 1). Campuran SL
juga secara signifikan mengurangi infektivitas G2P [4] dibandingkan
dengan GOS atau 2 # FL (data tidak ditampilkan). Hasil ini
menunjukkan bahwa 3 # SL dan 6 # SL bisa lebih efektif dalam
menghambat infeksi rotavirus manusia dalam kombinasi, tetapi efek
ini tergantung pada genotipe rotavirus.
GAMBAR 3 Susu oligosakarida mengurangi infektivitas
strain rotavirus manusia melalui efek pada virus dan bukan sel
MA104. Preinkubasi virus selama 2 jam dengan adanya
oligosakarida susu (2 # FL, GOS, 3 # SL, dan 6 # SL)
mengurangi infektivitas strain rotavirus manusia G1P [8] (A)
dan G2P [4] (B) (lihat Gambar 1, kondisi 2 untuk pengaturan
eksperimental), sedangkan preinkubasi sel dengan adanya
oligosakarida susu selama 24 jam tidak mengurangi
infektivitas kedua galur [G1P [8] (C) dan G2P [4] (D); lihat
Gambar 1, kondisi 3 untuk pengaturan eksperimental]. Data
berarti 6 SD, dan $ 3 percobaan independen. Infektivitas tanpa
adanya oligosakarida dianggap 100% (G1P [8]: 100% 6 10%,
G2P [4]: 100% 6 9%).
GAMBAR 4 Penambahan oligosakarida setelah penyerapan
virus mengurangi infektivitas strain rotavirus manusia dalam
sel MA104. Penambahan oligosakarida (2 # FL, GOS, 3 # SL,
dan 6 # SL) setelah penyerapan G1P [8] (A) dan G2P [4] (B)
selama 20 menit mengurangi infektivitas kedua strain (lihat
Gambar 1, kondisi 5 untuk pengaturan eksperimental). Data
berarti 6 SD, dan $ 3 percobaan. Infektivitas tanpa adanya
oligosakarida dianggap 100% (G1P [8]: 100% 6 10%, G2P [4]:
100% 6 18%) (garis putus-putus hitam). Data diekspresikan
relatif terhadap kontrol no-oligosaccharide. * Berbeda dari
kontrol, P, 0,01. GOS, galacto-oligosaccharide; MA104, sel
epitel ginjal monyet hijau Afrika; 2 # FL, 2 # - fucosyllactose;
3 # SL, 3 # -sialyllactose; 6 # SL, 6 # -sialyllactose.
Ucapan Terima Kasih
You can simply impress your audience and add a unique zing and appeal to your
Presentations. Get a modern PowerPoint Presentation that is beautifully designed.
I hope and I believe that this Template will your Time, Money and Reputation.
Tanggung jawab penulis adalah sebagai berikut — DRL:
merancang dan melakukan percobaan You can simplydan menganalisis
impress your data;
audience and add a unique zing and
MKE
You candan SR:
simply mengawasi
impress your proyek,
appealmerancang eksperimen
to your Presentations. Easy to dan
You can simply impress your
audience and add adata;
menganalisis unique zing
VTand dan RS:change
memberikan
colors, photosreagen
and Text. Idan saran
audience and add a unique zing and
appeal to your Presentations. Easy to hope and I believe that this Template
konseptual untuk appeal to your Presentations. Easy to
change colors, photos andmerancang
Text. I percobaan; DRLand
will your Time, Money dan SR: menulis
Reputation. change colors, photos and Text. I
hope and
draf awalI believe that thisdan
naskah; Template
semua penulis: memberikan ulasan kritis hope and I believe that this Template
will your Tim, Money and Reputation.
dan persetujuan akhir dari naskah. will your Time, Money and Reputation.
You can simply impress your You can simply impress your
audience and add a unique zing and audience and add a unique zing and
appeal to your Presentations. Easy to appeal to your Presentations. Easy to
change colors, photos and Text. I change colors, photos and Text. I
hope and I believe that this Template hope and I believe that this Template
will your Time, Money and Reputation. will your Time, Money and Reputation.
You can simply impress your You can simply impress your
audience and add a unique zing and audience and add a unique zing and
appeal to your Presentations. Easy to appeal to your Presentations. Easy to
change colors, photos and Text. change colors, photos and Text.
DAFTAR PUSTAKA
1. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012; 22: 1147–62.
2. Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, BH Clowers, German JB, Freeman SL, Killeen K, Grimm R, et al. A strategy for
notating the human milk glycome. J Agric Food Chem 2006; 54: 7471–80.
3. Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, Capretti R, Orazio G. Human milk oligosaccharides inhibit the adhesion to
Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res 2006; 59: 377–82.
4. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS.
Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr 2004; 145: 297-303.
5. Tate JE, Burton AH, Boschi-Pinto C, Parashar UD; WHO-Coordinated Global Rotavirus Surveillance Network. Global, regional, and
national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis 2016; 62 (Suppl 2): S96-105.
6. Jiang V, Jiang B, Tate J, Parashar UD, Patel MM. Performance of crime vaccines in developed and developing countries. Hum Vaccin
2010; 6: 532–42.
7. Plenge-Boig nig, Soto-Ramirez N, Karmaus W, Petersen G, Davis S, Forster J. Breastfeeding protects against acute gastroenteritis due
to rotavirus in infants. Eur J Pediatr 2010; 169: 1471–6.
8. Kurugo Z, Geylani S, Karaca Y, Umay F, Erensoy S, Vardar F, Bak M, Yaprak I, Ozkinay F, Ozkinay C. Rotavirus gastroenteritis among
children under five years of age in Izmir, Turkey. Turk J Pediatr 2003; 45: 290–4.
9. Das S, Sahoo GC, Das P, Singh UK, Jaiswal AK, Singh P, Kumar R, Kumar R. Evaluating the impact of breastfeeding on rotavirus
antigenemia and disease severity in Indian children. PLoS One 2016; 11: e0146243.
10. Jayashree S, Bhan MK, Kumar R, Bhandari N, Sazawal S. Protection against neonatal rotavirus infection by breast milk antibodies
and trypsin inhibitors. J Med Virol 1988; 26: 333–8.
11. Asensi MT, Martinez-Costa C, Buesa J. Anti-rotavirus antibodies in human milk: quantification and neutralizing activity. J Pediatric
Gastroenterologist Nutr 2006; 42: 560-7.
12. Newburg DS, Peterson JA, Ruiz-Palacios GM, Matson DO, Morrow AL, Shults J, Guerrero ML, Chaturvedi P, Newburg SO, Scallan
CD, et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998; 351: 1160-4.
13. Yu Y, Lasanajak Y, Song X, Hu L, Ramani S, Mickum ML, Ashline DJ, Prasad BV, Estes MK, Reinhold VN, et al. Human milk contains
novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol Cell Proteomics 2014; 13: 2944–60.
14. Hester SN, Chen X, Li M, Monaco MH, Comstock SS, Kuhlenschmidt TB, Kuhlenschmidt MS, Donovan SM. Human milk
oligosaccharides inhibit rotavirus infectivity in vitro and in acutely infected piglets. Br J Nutr 2013; 110: 1233–42.
15. Li M, Monaco MH, Wang M, Comstock SS, Kuhlenschmidt TB, Fahey GC Jr., Miller MJ, Kuhlenschmidt MS, Donovan SM. Human milk
oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota. ISME J 2014; 8:
1609-20.
16. Ciarlet M, Estes MK, Barone C, Ramig RF, Conner ME. Analysis of host range restriction determinants in the rabbit model: comparison
of immunologic and heterologous rotavirus infections. J Virol 1998; 72: 2341–51.
17. van Leeuwen SS, BJ Kuipers, Dijkhuizen L, Kamerling JP. Comparative structural characterization of 7 commercial galacto-oligosaccharide
(GOS) products. Carbohydr Res 2016; 425: 48–58.
18. Ciarlet M, Crawford SE, Cheng E, Blutt SE, Rice DA, Bergelson JM, Estes MK. VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells
but is not necessary for rotavirus attachment. J Virol 2002; 76: 1109-23.
19. Gutie´rrez M, Isa P, Sanchez-San Martin C, Prez-Vargas J, Espinosa R, Arias CF, Lpez S. Different rotavirus strains enter MA104 cells through
different endocytic pathways: the role of clathrin-mediated endocytosis. J Virol 2010; 84: 9161-9.
20. Zrate S, Cuadras MA, Espinosa R, Romero P, Jurez KO, Camacho-Nuez M, Arias CF, Lpez S. Interaction of rotaviruses with Hsc70 during cell
entry is mediated by VP5. J Virol 2003; 77: 7254–60.
21. Angeloni S, Ridet JL, Kusy N, Gao H, Crevoisier F, Guinchard S, Kochhar S, Sigrist H, Sprenger N. Glycoprofiling with micro-arrays of
glycoconjugates and lectins. Glycobiology 2005; 15: 31–41.
22. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H (O) antigen (Fuc alpha 1,
2 Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 2003; 278: 14112-20.
23. Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW. Prebiotic gal-actooligosaccharides reduce adherence of enteropathogenic Escherichia coli to
tissue culture cells. Infect Immun 2006; 74: 6920–8.
24. Schroten H, Hanisch FG, Hansman GS. Human norovirus interactions with GOS - blood group antigens and human milk oligosaccharides. J
Virol 2016; 90: 5855-9.
25. Weichert S, Koromyslova A, Singh BK, Hansman S, Jennewein S, Schroten H, Hansman GS. Structural basis for norovirus inhibition by human
milk oligosaccharides. J Virol 2016; 90: 4843–8.
26. Marriage BJ, Buck RH, Goehring KC, Oliver JS, Williams JA. Infants fed a lower calorie formula with 2 # FL show growth and 2 # FL uptake like
breast-fed infants. J Pediatr Gastroenterol Nutr 2015; 61: 649–58.
27. Hu L, Crawford SE, Czako R, Cortes-Penfield NW, Smith DF, Le Pendu J, Estes MK, Prasad BV. Cell attachment VP8 protein * of a human
rotavirus specifically interacts with A-type histo-blood group antigens. Nature 2012; 485: 256-9.
28. Huang P, Xia M, Tan M, Zhong W, Wei C, Wang L, Morrow A, Jiang X. Spike protein VP8 * of human rotavirus recognizes histo-blood group
antigens in a type-specific manner. J Virol 2012; 86: 4833–43.
29. Holscher HD, Davis SR, Tappenden KA. Human milk oligosaccharides influence the maturation of human intestinal Caco-2Bbe and HT-29 cell
lines. J Nutr 2014; 144: 586–91.
30. Kuntz S, Kunz C, Rudloff S. Oligosaccharides from human milk induce growth arrest via G2 / M by influencing growth-related cell cycle genes in
intestinal epithelial cells. Br J Nutr 2009; 101: 1306-15.
31. Kuntz S, Rudloff S, Kunz C. Oligosaccharides from human milk influencing growth-related characteristics of intestinally transformed and non-
transformed intestinal cells. Br J Nutr 2008; 99: 462–71.
32. Hester SN, Donovan SM. Individual and combined effects of nucleosides and human milk oligosaccharides on proliferation, apoptosis and necrosis
in a human fetal intestinal cell line. Food Nutrition Sci 2012; 3: 1567–76.
33. Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, Karandikar UC, Sastri NP, Conner ME, Opekun AR, et al. Human intestinal
enteroids: a new model for the study of human rotavirus infection, host restriction, and pathophysiology. J Virol 2015; 90: 43–56.
Thank You
Insert the Sub Title of Your Presentation